2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
*  Corresponding authors: Paulus Kirchhof, Institute of Cardiovascular Sciences, University of Birmingham, SWBH and UHB NHS trusts, IBR, Room 136, Wolfson Drive, Birmingham B15 2TT, United Kingdom, Tel: +44 121 4147042, E-mail: p.kirchhof@bham.ac.uk; Stefano Benussi, Department of Cardiovascular Surgery, University Hospital Zurich, Rämistrasse 100, 8091 Zürich, Switzerland, Tel: +41(0)788933835, E-mail: stefano.benussi@usz.ch.
Paulus
P
Kirchhof
*  Corresponding authors: Paulus Kirchhof, Institute of Cardiovascular Sciences, University of Birmingham, SWBH and UHB NHS trusts, IBR, Room 136, Wolfson Drive, Birmingham B15 2TT, United Kingdom, Tel: +44 121 4147042, E-mail: p.kirchhof@bham.ac.uk; Stefano Benussi, Department of Cardiovascular Surgery, University Hospital Zurich, Rämistrasse 100, 8091 Zürich, Switzerland, Tel: +41(0)788933835, E-mail: stefano.benussi@usz.ch.
Stefano
S
Benussi
Dipak
D
Kotecha
Anders
A
Ahlsson
Dan
D
Atar
Barbara
B
Casadei
Manuel
M
Castella
Hans-Christoph
HC
Diener
Hein
H
Heidbuchel
Jeroen
J
Hendriks
Gerhard
G
Hindricks
Antonis S
AS
Manolis
Jonas
J
Oldgren
Bogdan Alexandru
BA
Popescu
Ulrich
U
Schotten
Bart
B
Van Putte
Panagiotis
P
Vardas
Stefan
S
Agewall
John
J
Camm
Gonzalo
G
Baron Esquivias
Werner
W
Budts
Scipione
S
Carerj
Filip
F
Casselman
Antonio
A
Coca
Raffaele
R
De Caterina
Spiridon
S
Deftereos
Dobromir
D
Dobrev
José M
JM
Ferro
Gerasimos
G
Filippatos
Donna
D
Fitzsimons
Bulent
B
Gorenek
Maxine
M
Guenoun
Stefan H
SH
Hohnloser
Philippe
P
Kolh
Gregory Y H
GY
Lip
Athanasios
A
Manolis
John
J
McMurray
Piotr
P
Ponikowski
Raphael
R
Rosenhek
Frank
F
Ruschitzka
Irina
I
Savelieva
Sanjay
S
Sharma
Piotr
P
Suwalski
Juan Luis
JL
Tamargo
Clare J
CJ
Taylor
Isabelle C
IC
Van Gelder
Adriaan A
AA
Voors
Stephan
S
Windecker
Jose Luis
JL
Zamorano
Katja
K
Zeppenfeld
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods; D015897:Comorbidity; D019468:Disease Management; D004562:Electrocardiography; D019317:Evidence-Based Medicine / Q000379:methods; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D008403:Mass Screening / Q000379:methods; D015995:Prevalence; D012307:Risk Factors; D012737:Sex Factors; D020521:Stroke / Q000209:etiology / Q000517:prevention & control
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants
AF surgery; Antiarrhythmic drugs; Anticoagulation; Atrial fibrillation; Cardioversion; Catheter ablation; Guidelines; Left atrial ablation; Left atrial appendage occlusion; Non-vitamin K antagonist oral anticoagulants; Pulmonary vein isolation; Rate control; Rhythm control; Upstream therapy; Valve repair; Vitamin K antagonists